Viela Bio

YTD

ALL

Why Robinhood?

You can watch Viela Bio and buy or sell other stocks, ETFs, and their options commission-free!

About VIE

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company’s portfolio selectively targets shared critical pathways that are the root cause of disease.

CEO

Zheng Bin Yao, PhD

CEOZheng Bin Yao, PhD

Employees

—

Employees—

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

2017

Founded2017

Employees

—

Employees—

VIE Key Statistics

Market cap

2.91B

Market cap2.91B

Price-Earnings ratio

-18.64

Price-Earnings ratio-18.64

Dividend yield

—

Dividend yield—

Average volume

755.94K

Average volume755.94K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$65.00

52 Week high$65.00

52 Week low

$25.02

52 Week low$25.02

People also own

Based on the portfolios of people who own VIE. This list is generated using Robinhood data, and it’s not a recommendation.